A detailed history of Wolverine Trading, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Wolverine Trading, LLC holds 24,565 shares of AVXL stock, worth $183,009. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,565
Previous 21,200 15.87%
Holding current value
$183,009
Previous $89,000 56.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.11 - $7.04 $100,962 - $172,937
24,565 New
24,565 $139,000
Q4 2023

Feb 14, 2024

BUY
$5.04 - $9.95 $65,459 - $129,230
12,988 New
12,988 $120,000
Q3 2022

Nov 14, 2022

BUY
$8.9 - $12.86 $78,756 - $113,798
8,849 Added 55.74%
24,724 $241,000
Q2 2022

Aug 15, 2022

BUY
$7.31 - $12.84 $116,046 - $203,835
15,875 New
15,875 $157,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $581M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.